STOCK TITAN
  1. Home
  2. News
  3. CLOV

Clover Health Investments Corp - CLOV STOCK NEWS

Welcome to our dedicated news page for Clover Health Investments (Ticker: CLOV), a resource for investors and traders seeking the latest updates and insights on Clover Health Investments.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Clover Health Investments's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Clover Health Investments's position in the market.

News
Clover Health Provides Notice Associated with Previously Disclosed Settlement of Shareholder Derivative Actions
Rhea-AI Summary
Clover Health Investments, Corp. has reached an agreement to resolve shareholder derivative actions in four jurisdictions related to its de-SPAC transaction. The Settlement involves corporate governance enhancements without any monetary payment, pending final court approval.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.77%
Tags
none
-
News
Clover Health Launches New Clinical Program in Partnership with Quartet Health to Address Serious Mental Illness
Rhea-AI Summary
Clover Health partners with Quartet Health to enhance care for members with serious mental illness through Clover Home Care. Quartet's expertise in behavioral health will complement Clover's home-based care model, improving outcomes for underserved patient populations.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.9%
Tags
partnership
-
News
Clover Health Reports Fourth Quarter and Full Year 2023 Financial Results; Delivers Continued Momentum in Financial Performance and Provides Full-Year 2024 Guidance
Rhea-AI Summary
Clover Health Investments, Corp. (CLOV) reported improved financial results for full-year 2023, with Insurance MCR at 81.2% and fourth quarter MCR at 82.4%. The company saw a net loss reduction of $126.2 million and an increase in Adjusted EBITDA by $245.7 million year-over-year. Clover issued 2024 guidance projecting Insurance MCR range of 79% - 83% and up to $20 million of Adjusted EBITDA profitability at the high end of the range.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.99%
Tags
earnings
News
Industry Veteran Clay Thornton Joins Clover Health as CFO of Medicare Advantage
Rhea-AI Summary
Clover Health appoints Clay Thornton as Chief Financial Officer of its Medicare Advantage division, bringing a decade of healthcare financial management experience. Thornton's track record includes significant achievements in driving financial strategies for quality outcomes and business expansion. His expertise aligns with Clover's PPO-first product strategy and state-of-the-art technology.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.4%
Tags
none
-
News
Clover Health to Report Fourth Quarter and Full Year 2023 Financial Results on March 12, 2024
Rhea-AI Summary
Clover Health Investments, Corp. (CLOV) will report Q4 and full year 2023 financial results on March 12, 2024. A conference call and webcast will follow to discuss business and financial performance.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.22%
Tags
conferences earnings
-
News
Clover Health Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
Rhea-AI Summary
Clover Health Investments, Corp. (CLOV) granted a restricted stock unit award to a newly hired employee under the 2022 Inducement Award Plan. The employee has the right to receive 902,061 shares of the Company's Class A Common Stock, with vesting over a four-year period. This award aims to attract new talent to the company.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
News
Clover Health Provides Business Update and Full-Year 2024 Objectives
Rhea-AI Summary
Clover Health Investments, Corp. (NASDAQ: CLOV) aims for Adjusted EBITDA profitability in 2024. CEO Andrew Toy highlights the success in 2023 and plans for 2024, focusing on technology, programs, and expanding offerings. The company targets profitability through improved MA-plan performance and reduced operational spend.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.1%
Tags
none
-
News
PCP Use of Clover Assistant Correlated with Increased Medication Fills for Patients who Were Previously Non-Adherent
Rhea-AI Summary
Clover Health Investments, Corp. (NASDAQ: CLOV) released research demonstrating Clover Assistant’s impact on medication adherence in the Medicare Advantage Stars program. The study examined the correlation between PCP use of Clover Assistant and levels of adherence to prescribed medications for common chronic conditions. Dr. Kumar Dharmarajan, Chief Medical Officer of Clover Assistant, highlighted the importance of medication adherence for chronic health conditions.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.02%
Tags
none
-
News
Clover Health Announces Departure of Chief Financial Officer; Reiterates Most Recently Issued Financial Guidance for 2023
Rhea-AI Summary
Clover Health Investments, Corp. (Nasdaq: CLOV) announced that its Chief Financial Officer, Scott J. Leffler, will be leaving the company to pursue another professional opportunity. The company has initiated a search for a successor CFO, with Lee A. Shapiro, Chair of the Audit Committee, leading the search committee. The company has engaged a leading executive search firm to assist in finding a new CFO for the next stage of its growth.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
News
Clover Health to Present at 42nd Annual J.P. Morgan Healthcare Conference on January 11, 2024
Rhea-AI Summary
Clover Health Investments, Corp. (NASDAQ: CLOV) announced that its CEO, Andrew Toy, will present at the 42nd Annual J.P. Morgan Healthcare Conference on January 11, 2024, at 12:00 p.m. Eastern Time. A live webcast of the presentation will be accessible from Clover Health's investor relations website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.92%
Tags
conferences
Stock CLOV logo
Clover Health Investments Corp

Nasdaq:CLOV

CLOV Rankings

#3340 Ranked by Market Cap
#4425 Ranked by Stock Gains
N/A Ranked by Dividends

CLOV Stock Data

331.90M
375.12M
7.38%
24.46%
8.88%
Direct Health and Medical Insurance Carriers
Finance and Insurance
Link
United States
Franklin

About CLOV

clover health (nasdaq: clov) is a physician enablement company focused on seniors who have historically lacked access to affordable, high-quality healthcarewe aim to provide great care, in a sustainable way, by having a business model built around improving medical outcomes while lowering avoidable costs. we do this while taking a holistic approach to understanding the health needs and social risk factors of those under our care. this strategy is underpinned by our proprietary software platform, the clover assistant, which is designed to aggregate patient data from across the health ecosystem to support clinical decision-making by presenting physicians and other providers with real-time, personalized recommendations at the point of care.making care more accessible is at the heart of our business, and we believe patients should have the freedom to choose their doctors. we offer affordable medicare advantage plans with extensive benefits, provide primary care physicians with the clover a